Expression of Livin mRNA and Bcl-2, p53 proteins in pancreatic carcinoma
Author:
Affiliation:

Clc Number:

R 735.9

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Abstract:Objective:To study the expression of the apoptosis inhibitor Livin gene and its relationship with the expression of Bcl-2, p53 proteins in pancreatic carcinoma.
    Methods :The expression of Livin mRNA was investigated by reverse transcriptase polymerase chain reaction (RT-PCR) in pancreatic carcinoma tissue of 52 cases and normal pancreatic tissue of 12 cases. The expression of Bcl-2 and p53 was detected by immunohistochemical assay.
    Results:The expression rate of Livin gene in pancreatic carcinoma tissue was 71.2%, which was obviously higher than that in normal pancreatic tissue (P<0.01). There was relationship between Livin gene expression and the differentiation and lymph node metastasis of pancreatic carcinoma (P<0.05). The expression of Livin gene was correlated with Bcl-2 expression, but was not with p53 expression.
    Conclusions:Livin gene may play an important role in the pathogenesis of pancreatic carcinoma. The up-regulated expression of Livin and Bcl-2 may play synergetic roles in the process of carcinogenesis of pancreatic carcinoma. There was no relationship between Livin expression and dysfunction of p53.

    Reference
    Related
    Cited by
Get Citation

LIU Yuan, BAI Jie, GENG Donghua, LIU Jingang.Expression of Livin mRNA and Bcl-2, p53 proteins in pancreatic carcinoma[J]. Chin J Gen Surg,2008,17(9):8-873.
DOI:10.7659/j. issn.1005-6947.2008.09.008

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 01,1900
  • Revised:January 01,1900
  • Adopted:
  • Online: September 25,2008
  • Published: